These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31401971)

  • 21. Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
    Diener HC; Sacco RL; Easton JD; Granger CB; Bar M; Bernstein RA; Brainin M; Brueckmann M; Cronin L; Donnan G; Gdovinová Z; Grauer C; Kleine E; Kleinig TJ; Lyrer P; Martins S; Meyerhoff J; Milling T; Pfeilschifter W; Poli S; Reif M; Rose DZ; Šaňák D; Schäbitz WR
    Stroke; 2020 Jun; 51(6):1758-1765. PubMed ID: 32404035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source.
    Ospel JM; Singh N; Marko M; Almekhlafi M; Dowlatshahi D; Puig J; Demchuk A; Coutts SB; Hill MD; Menon BK; Goyal M
    Stroke; 2020 Jun; 51(6):1743-1749. PubMed ID: 32375585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ipsilateral Nonstenotic Carotid Disease in Minor Ischemic Stroke: an Exploratory Analysis of The POINT Randomized Clinical Trial.
    Bulwa Z; Saleh Velez FG; Brorson JR; Pinto CB
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105115. PubMed ID: 33066893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Nonstenotic Carotid Plaque in Stroke Due to Atrial Fibrillation Compared to Embolic Stroke of Undetermined Source.
    Siegler JE; Thon JM; Woo JH; Do D; Messé SR; Cucchiara B
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104289. PubMed ID: 31353245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial.
    Bosch J; Pearce LA; Sharma M; Canavan M; Whiteley WN; Mikulík R; Mundl H; Yusuf S; Hart RG; O'Donnell MJ
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106404. PubMed ID: 35292423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial.
    Hart RG; Sharma M; Mundl H; Shoamanesh A; Kasner SE; Berkowitz SD; Pare G; Kirsch B; Pogue J; Pater C; Peters G; Davalos A; Lang W; Wang Y; Wang Y; Cunha L; Eckstein J; Tatlisumak T; Shamalov N; Mikulik R; Lavados P; Hankey GJ; Czlonkowska A; Toni D; Ameriso SF; Gagliardi RJ; Amarenco P; Bereczki D; Uchiyama S; Lindgren A; Endres M; Brouns R; Yoon BW; Ntaios G; Veltkamp R; Muir KW; Ozturk S; Arauz A; Bornstein N; Bryer A; O'Donnell MJ; Weitz J; Peacock F; Themeles E; Connolly SJ
    Eur Stroke J; 2016 Sep; 1(3):146-154. PubMed ID: 31008276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large but Nonstenotic Carotid Artery Plaque in Patients With a History of Embolic Stroke of Undetermined Source.
    Komatsu T; Iguchi Y; Arai A; Sakuta K; Sakai K; Terasawa Y; Mitsumura H; Matsushima M
    Stroke; 2018 Dec; 49(12):3054-3056. PubMed ID: 30571401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
    Sharma M; Hart RG; Smith EE; Bosch J; Eikelboom JW; Connolly SJ; Dyal L; Reeh KW; Casanova A; Diaz R; Lopez-Jaramillo P; Ertl G; Störk S; Dagenais GR; Lonn EM; Ryden L; Tonkin AM; Varigos JD; Bhatt DL; Branch KRH; Probstfield JL; Kim JH; O'Donnell M; Vinereanu D; A A Fox K; Liang Y; Liu L; Zhu J; Pogosova N; Maggioni AP; Avezum A; Piegas LS; Keltai K; Keltai M; Berkowitz SD; Yusuf S
    Stroke; 2020 Oct; 51(10):2901-2909. PubMed ID: 32951537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hybrid automated event adjudication system for clinical trials.
    Yuan F; Bosch J; Eikelboom J; Dagenais GR; Connolly S; Belanger J; Marsden T; Tang C; Swaminathan B; Renters M; Dyal L; Bangdiwala SI
    Clin Trials; 2023 Apr; 20(2):166-175. PubMed ID: 36734212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial.
    Xie X; Jing J; Meng X; Johnston SC; Bath PM; Li Z; Zhao X; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
    Stroke; 2024 Jul; 55(7):1739-1747. PubMed ID: 38860396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source.
    Kamel H; Pearce LA; Ntaios G; Gladstone DJ; Perera K; Roine RO; Meseguer E; Shoamanesh A; Berkowitz SD; Mundl H; Sharma M; Connolly SJ; Hart RG; Healey JS
    Stroke; 2020 Mar; 51(3):938-943. PubMed ID: 31893985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
    Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN; Pap AF; Berkowitz SD; Muehlhofer E; Haskell L; Brasil D; Madaric J; Sillesen H; Szalay D; Bauersachs R
    Circulation; 2020 Dec; 142(23):2219-2230. PubMed ID: 33138628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
    Diener HC; Sacco RL; Easton JD; Granger CB; Bernstein RA; Uchiyama S; Kreuzer J; Cronin L; Cotton D; Grauer C; Brueckmann M; Chernyatina M; Donnan G; Ferro JM; Grond M; Kallmünzer B; Krupinski J; Lee BC; Lemmens R; Masjuan J; Odinak M; Saver JL; Schellinger PD; Toni D; Toyoda K;
    N Engl J Med; 2019 May; 380(20):1906-1917. PubMed ID: 31091372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
    Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
    Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.
    Uchiyama S; Toyoda K; Lee BC; Liou CW; Wong LKS; Grauer C; Brueckmann M; Taniguchi A; Urano Y; Easton JD;
    Stroke; 2021 Mar; 52(3):1069-1073. PubMed ID: 33588594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
    Del Brutto VJ; Diener HC; Easton JD; Granger CB; Cronin L; Kleine E; Grauer C; Brueckmann M; Toyoda K; Schellinger PD; Lyrer P; Molina CA; Chutinet A; Bladin CF; Estol CJ; Sacco RL
    J Am Heart Assoc; 2022 Jun; 11(11):e023545. PubMed ID: 35656979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.
    Branch KR; Probstfield JL; Eikelboom JW; Bosch J; Maggioni AP; Cheng RK; Bhatt DL; Avezum A; Fox KAA; Connolly SJ; Shestakovska O; Yusuf S
    Circulation; 2019 Aug; 140(7):529-537. PubMed ID: 31163978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke Outcomes in the COMPASS Trial.
    Sharma M; Hart RG; Connolly SJ; Bosch J; Shestakovska O; Ng KKH; Catanese L; Keltai K; Aboyans V; Alings M; Ha JW; Varigos J; Tonkin A; O'Donnell M; Bhatt DL; Fox K; Maggioni A; Berkowitz SD; Bruns NC; Yusuf S; Eikelboom JW
    Circulation; 2019 Feb; 139(9):1134-1145. PubMed ID: 30667279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Lancet Neurol; 2017 Apr; 16(4):301-310. PubMed ID: 28238711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.